ForteBio is now part of the Sartorius group. Click here for more

Anti-hIgG Fc Capture (AHC) Biosensors

For Label-Free Immobilization and Subsequent Kinetic Characterization of Human IgG or other Human Fc-containing Proteins

  • Capture-based immobilization of human Fc-containing proteins
  • Regenerable and cost-effective format
  • Compatible with crude samples and complex media

Anti-hIgG Fc Capture (AHC) Biosensors

Anti-Human IgG Fc Capture (AHC) biosensors enable kinetic characterization of macromolecular interactions between human Fc-containing proteins and target analytes. Immobilization of human Fc-containing proteins is achieved through a factory immobilized anti-human Fc-specific antibody whose high-affinity for the human Fc domain provides the stable baseline required for demanding kinetics applications. Cost-effective regeneration of the biosensors and the ability to directly immobilize human Fc-containing proteins from crude matrices make the AHC biosensor extremely useful in high throughput applications.

Resources of Anti-hIgG Fc Capture (AHC) Biosensors

Data Sheet Anti-human IgG Fc Capture (AHC) Biosensors

Capture-based immobilization of human Fc-containing proteins Regenerable and cost-effective format Compatible with crude samples and complex media

Read more

Flyer BLI Biosensors Selection Guide

Read this document which is helpful in the selection of Biosensor with their detail information.

Read more

Flyer Recent insights into COVID-19 binding epitopes

The novel coronavirus, COVID-19, has been declared a pandemic by the world health organization (WHO). As it spreads, researchers are mobilizing to understand the virus’s binding mechanisms as a first step in the development of a vaccine. Below are examples of recent publications highlighting insights into these binding mechanisms.

Read more

We use cookies to personalize content and improve your browsing experience.

We also use analytics & advertising services. To opt-out click for more information.